21. E. Prandovszky, E. Gaskell, H. Martin, J. P. Dubey, J. P. Webster, and G.A. McConkey, "The Neurotropic Parasite Toxoplasma gondii Increases Dopamine Metabolism," PloS One 6, no. 9 (2011): e23866.

22. См.: V. J. Castillo-Morales, K. Y. Acosta Viana, E.D.S. Guzmán-Marín, M. Jiménez-Coello, J. C. Segura-Correa, A. J. Aguilar-Caballero, and A. Ortega-Pacheco, "Prevalence and Risk Factors of Toxoplasma gondii Infection in Domestic Cats from the Tropics of Mexico Using Serological and Molecular Tests," Interdisciplinary Perspectives on Infectious Diseases 2012 (2012): 529108.

23. E. F. Torrey and R. H. Yolken, "The Schizophrenia–Rheumatoid Arthritis Connection: Infectious, Immune, or Both?" Brain, Behavior, and Immunity 15, no. 4 (2001): 401–410.

24. J. P. Webster, P.H.L. Lamberton, C. A. Donnelly, E. F. Torrey, "Parasites as Causative Agents of Human Affective Disorders? The Impact of Anti-Psychotic, Mood-Stabilizer and Anti-Parasite Medication on Toxoplasma gondii's Ability to Alter Host Behaviour," Proceedings of the Royal Society B: Biological Sciences 273, no. 1589 (2006): 1023–1030.

25. D. W. Niebuhr, A. M. Millikan, D. N. Cowan, R. Yolken, Y. Li, and N. S. Weber, "Selected Infectious Agents and Risk of Schizophrenia among US Military Personnel," American Journal of Psychiatry 165, no. 1 (2008): 99–106.

26. R. H. Yolken, F. B. Dickerson, and E. Fuller Torrey, "Toxoplasma and Schizophrenia," Parasite Immunology 31, no. 11 (2009): 706–715.

27. C. Poirotte, P. M. Kappeler, B. Ngoubangoye, S. Bourgeois, M. Moussodji, and M. J. Charpentier, "Morbid Attraction to Leopard Urine in Toxoplasma-Infected Chimpanzees," Current Biology 26, no. 3 (2016): R98–R99.